Replies to post #114660 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

a 2nd MANF ODD for RAO would be be huge

http://globenewswire.com/news-release/2014/12/19/692929/10113053/en/Amarantus-Submits-Orphan-Drug-Designation-Application-to-US-FDA-for-Treatment-of-Retinal-Artery-Occlusion-With-Product-Candidate-MANF.html

[GS1]

Well said. I agree 100%. Eltoprazine is game changer.